NovaSeq X Series 25B Reagent Kits
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), under the Department of Health and Human Services, has issued a Notice of Intent to award a Firm-Fixed-Price Purchase Order to Illumina Inc. for NovaSeq X Series 25B Reagent Kits. This action is based on Illumina Inc. being identified as the sole known responsible source. Interested small businesses are invited to submit capability statements to challenge this sole-source determination.
Scope of Work
The requirement is for NovaSeq X Series 25B Reagent Kits to provide supplies for the Neurodegenerative Diseases Research Unit. These reagents are essential for sequencing DNA samples on Illumina-manufactured NovaSeq sequencing systems. A key requirement is that the reagents must be fully compatible with and perform optimally in Illumina-manufactured systems and standardized protocols. The place of performance is Bethesda, MD.
Contract & Timeline
- Contract Type: Firm-Fixed-Price Purchase Order.
- Set-Aside: Not formally set-aside, but special consideration is given to small businesses (8(a), service-disabled veteran owned, HUBZone, small disadvantaged, veteran-owned, women-owned) who can demonstrate capability.
- Response Due: May 7, 2026, by 6:00 a.m. EDT.
- Published: April 27, 2026.
- Anticipated Award: Approximately five days after the notice date, pending the Government's determination regarding other potential vendors.
Submission & Evaluation
This is not a request for competitive quotes. Instead, it is an opportunity for interested small businesses to submit a written capability statement. The statement should clearly demonstrate their ability to meet the specified requirements. The Government will review these responses to determine if the award should be competed.
Contact Information
For submissions and inquiries, contact David Shen at david.shen@nih.gov.